Evaluation of Intravenous and Intraperitoneal Pharmacokinetics of Dalbavancin in Peritoneal Dialysis Patients

NCT02940730 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Infectious Peritonitis

Interventions

DRUG: Dalbavancin via Intravenous Administration
DRUG: Dalbavancin via Intraperitoneal Administration

Sponsor

University of Colorado, Denver